中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/30323
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1511679      Online Users : 460
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > College of Medicine > School of Medicine > Journal articles >  Item 310903500/30323
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/30323


    Title: Examination of the inhibitory effect of norathyriol in formylmethionyl-leucyl-phenylalanine-induced respiratory burst in rat neutrophils
    Authors: Hsu, MF;Raung, SL;Tsao, LT;Lin, CN;Wang, JP
    Contributors: 醫學院醫學系生化學科;TAICHUNG VET GEN HOSP,DEPT MED RES,TAICHUNG,TAIWAN;KAOHSIUNG MED COLL,SCH PHARM,KAOHSIUNG,TAIWAN;CHINA MED COLL,DEPT BIOCHEM,TAICHUNG,TAIWAN
    Date: 1997
    Issue Date: 2010-09-24 14:53:15 (UTC+8)
    Publisher: PERGAMON-ELSEVIER SCIENCE LTD
    Abstract: TPS is a new tumor marker immunoassay that indicates tumor proliferative rate rather than tumor burden. Thirty-nine patients with non-small cell lung cancer (NSCLC), including 18 cases with recurrence and 21 cases without recurrence 1 year postoperation, were enrolled in this study. The serial serum levels of tissue polypeptide specific antigen (TPS) were measured before operation and 1 week, 4 weeks, 3 months, 6 months, 9 months, and 12 months after operation, using an immunoradiometric assay (IRMA), for early detection of recurrence. The results revealed that mean serum values of TPS were higher in 18 patients with recurrent cancer (103.5, 69.2, 88.1, 137.0, 108.6, 170.5, and 106.3 U/l) when compared with 21 patients without recurrent cancer (86.7, 53.0, 54.5, 57.4, 52.3, 52.0, and 58.6 U/l), preoperation and at all times after operation. If the TPS serum level 1 week after operation was considered as the baseline level (1x), elevated TPS ratios were higher in 18 patients with recurrence (1.2x, 2.5x, 2.1x, 4.3x, and 3.0x) when compared with 21 patients without recurrence (1.1x, 1.1x, 1.0x, 1.0x, and 1.1x), 4 weeks to 12 months after operation. We conclude that TPS is a suitable marker for early prediction of NSCLC recurrence. Patients with recurrent NSCLC within 1 year postoperation showed higher serum TPS levels and elevated TPS ratios than patients without recurrent NSCLC.
    Relation: FREE RADICAL BIOLOGY AND MEDICINE 23(7):1035-1045
    Appears in Collections:[School of Medicine] Journal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback